![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 44, 29272-29277, October 30, 1998
2-Glycoprotein I Macrophage Interactions
From the Department of Cell Biology, The University of Texas
M. D. Anderson Cancer Center, Houston, Texas 77030
The binding and uptake of phosphatidylserine
(PS)-expressing cells appears to involve multiple receptor-mediated
systems that recognize the lipid either directly or indirectly through
intermediate proteins that form a molecular bridge between the cells.
Here we show that
2-glycoprotein I
(
2GPI), a 50-kDa serum glycoprotein, binds PS-containing
vesicles and serves as an intermediate for the interaction of these
vesicles with macrophages. Chemical modification of lysines and
cysteines abolished
2GPI-dependent PS uptake
by inhibiting the binding of PS to
2GPI and the binding
of PS·
2GPI complex to macrophages, respectively.
Recognition was mediated by
2GPI and not by the lipid
because antibodies to
2GPI inhibited binding of the
complex to macrophages. These results indicate that human
(THP-1-derived) macrophages bind
2GPI only after it is
bound to its lipid ligand. Competition experiments with monosaccharides that inhibit lectin-dependent interactions, and
PS·
2GPI binding experiments using deglycosylated
2GPI, suggested that carbohydrate residues were not
required for macrophage recognition of the complex. Antibodies to
putative macrophage PS receptors (CD36, CD68, and CD14) did not inhibit
uptake of the complex. These data suggest that
2GPI can
bind cells that fail to maintain membrane lipid asymmetry and generate
a specific bridging moiety that is recognized for clearance by a
phagocyte receptor that is distinct from CD36, CD68, and CD14.
This article has been cited by other articles:
![]() |
S. N. Maiti, K. Balasubramanian, J. A. Ramoth, and A. J. Schroit {beta}-2-Glycoprotein 1-dependent Macrophage Uptake of Apoptotic Cells: BINDING TO LIPOPROTEIN RECEPTOR-RELATED PROTEIN RECEPTOR FAMILY MEMBERS J. Biol. Chem., February 15, 2008; 283(7): 3761 - 3766. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Munoz, S. Franz, F. Pausch, B. Furnrohr, A. Sheriff, B. Vogt, P. M. Kern, W. Baum, C. Stach, D. von Laer, et al. The influence on the immunomodulatory effects of dying and dead cells of Annexin V J. Leukoc. Biol., January 1, 2007; 81(1): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Blank, I. Krause, L. Magrini, G. Spina, J. Kalil, S. Jacobsen, H. J. Thiesen, M. W. Cunningham, L. Guilherme, and Y. Shoenfeld Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome Rheumatology, July 1, 2006; 45(7): 833 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Buttari, E. Profumo, V. Mattei, A. Siracusano, E. Ortona, P. Margutti, B. Salvati, M. Sorice, and R. Rigano Oxidized {beta}2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response Blood, December 1, 2005; 106(12): 3880 - 3887. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fan, S. Krahling, D. Smith, P. Williamson, and R. A. Schlegel Macrophage Surface Expression of Annexins I and II in the Phagocytosis of Apoptotic Lymphocytes Mol. Biol. Cell, June 1, 2004; 15(6): 2863 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ozturk, I. C. Haznedaroglu, M. Turgut, and H. Goker Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia Clinical and Applied Thrombosis/Hemostasis, April 1, 2004; 10(2): 89 - 126. [Abstract] [PDF] |
||||
![]() |
M. Merten, S. Motamedy, S. Ramamurthy, F.C. Arnett, and P. Thiagarajan Sulfatides: Targets for Anti-Phospholipid Antibodies Circulation, October 28, 2003; 108(17): 2082 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Kagan, G. G. Borisenko, B. F. Serinkan, Y. Y. Tyurina, V. A. Tyurin, J. Jiang, S. X. Liu, A. A. Shvedova, J. P. Fabisiak, W. Uthaisang, et al. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L1 - L17. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Cocca, A. M. Cline, and M. Z. Radic Blebs and Apoptotic Bodies Are B Cell Autoantigens J. Immunol., July 1, 2002; 169(1): 159 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Cocca, S. N. Seal, P. D'Agnillo, Y. M. Mueller, P. D. Katsikis, J. Rauch, M. Weigert, and M. Z. Radic Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells PNAS, November 20, 2001; 98(24): 13826 - 13831. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Hoffmann, A. M. deCathelineau, C. A. Ogden, Y. Leverrier, D. L. Bratton, D. L. Daleke, A. J. Ridley, V. A. Fadok, and P. M. Henson Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells J. Cell Biol., November 12, 2001; 155(4): 649 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lindner, J. Song, F. Xu, A. L. Klibanov, K. Singbartl, K. Ley, and S. Kaul Noninvasive Ultrasound Imaging of Inflammation Using Microbubbles Targeted to Activated Leukocytes Circulation, November 28, 2000; 102(22): 2745 - 2750. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Terpstra, E. S. van Amersfoort, A. G. van Velzen, J. Kuiper, and T. J. C. van Berkel Hepatic and Extrahepatic Scavenger Receptors : Function in Relation to Disease Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1860 - 1872. [Full Text] [PDF] |
||||
![]() |
Y. Sheng, S. W. Reddel, H. Herzog, Y. X. Wang, T. Brighton, M. P. France, S. A. Robertson, and S. A. Krilis Impaired Thrombin Generation in beta 2-Glycoprotein I Null Mice J. Biol. Chem., April 20, 2001; 276(17): 13817 - 13821. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |